1. Home
  2. BIDU vs RMD Comparison

BIDU vs RMD Comparison

Compare BIDU & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Baidu Inc. ADS

BIDU

Baidu Inc. ADS

HOLD

Current Price

$77.71

Market Cap

29.0B

Sector

Technology

ML Signal

HOLD

Logo ResMed Inc.

RMD

ResMed Inc.

HOLD

Current Price

$252.37

Market Cap

33.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BIDU
RMD
Founded
2000
1989
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.0B
33.6B
IPO Year
2005
1996

Fundamental Metrics

Financial Performance
Metric
BIDU
RMD
Price
$77.71
$252.37
Analyst Decision
Buy
Buy
Analyst Count
31
20
Target Price
$144.82
★ $251.99
AVG Volume (30 Days)
★ 1.8M
851.7K
Earning Date
11-17-2026
10-29-2026
Dividend Yield
N/A
★ 1.07%
EPS Growth
N/A
★ 9.67
EPS
N/A
★ 10.43
Revenue
N/A
★ $2,957,013,000.00
Revenue This Year
N/A
$2.59
Revenue Next Year
$6.19
$6.92
P/E Ratio
$42.45
★ $23.68
Revenue Growth
N/A
★ 13.44
52 Week Low
$78.20
$180.27
52 Week High
$165.30
$277.67

Technical Indicators

Market Signals
Indicator
BIDU
RMD
Relative Strength Index (RSI) 27.79 76.35
Support Level N/A $247.01
Resistance Level $93.83 $262.16
Average True Range (ATR) 1.93 5.28
MACD -0.26 2.35
Stochastic Oscillator 9.41 99.03

Price Performance

Historical Comparison
BIDU
RMD

About BIDU Baidu Inc. ADS

Most of Baidu's revenue comes from Baidu core, with the rest coming from video-streaming subsidiary iQiyi. The firm's main businesses include online marketing services from its search engine, AI cloud infrastructure, AI applications, AI marketing, and autonomous driving.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea, combined with aging populations and increasing prevalence of obesity, is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.

Share on Social Networks: